← FDA DRUG APPROVALS

FDA ANDA · ANDA091458

ROCURONIUM BROMIDE

Sponsor: SAGENT PHARMS INC

APPLICATION
ANDA091458
TYPE
ANDA
ORIGINAL APPROVAL
2010-07-28
LATEST ACTION
2020-06-25
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ROCURONIUM BROMIDEPrescription
ROCURONIUM BROMIDE 50MG/5ML (10MG/ML) · INJECTABLE · INJECTION
ROCURONIUM BROMIDEPrescription
ROCURONIUM BROMIDE 100MG/10ML (10MG/ML) · INJECTABLE · INJECTION

Approval history

2020-06-25Labeling · Supplement 13 · standardAP
2018-07-26Labeling · Supplement 11 · standardAP
2015-10-16Labeling · Supplement 4 · standardAP
2012-10-16Labeling · Supplement 3 · standardAP
2011-09-27Labeling · Supplement 1AP
2010-07-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →